Search

Pages

1. • Journal article

   • 

   Blunted rise in intracellular calcium in CD4+ T cells in response to mitogen following autologous bone marrow transplantation.

   Guillaume, T. Hamdan, O Staquet, P. Sekhavat, M. Chatelain, Bernard[UCL] Bosly, André[UCL] Rubinstein, D B Humblet, Yves[UCL] Doyen, Chantal[UCL] Coiffier, B. (1993) British journal of haematology — Vol. 84, no. 1, p. 131-6 (1993)
2. • Speech

   • 

   Safety of prophylactic use of darbepoetin alfa in patients with diffuse large B-Cell lymphoma (DLBCL) treated with R-CHOP 14 or RCHOP21: Preliminary results of the LNH03-6B randomized GELA study.

   Delarue, R. Mounier, N. Haioun, C. Coiffier, B. Gisselbrecht, C. Ghesquieres, H. Lederlin, P. Blanc, M. Recher, C. Hermine, O. Reyes, F. Tilly, H. Bosly, André[UCL] (2006) 48th Annual Meeting of the American-Society-of-Hematology — Orlando(Fl)
3. • Journal article

   • 

   Randomized comparison of ACVBP and m-BACOD in the treatment of patients with low-risk aggressive lymphoma: The LNH87-1 study

   Tilly, H. Mounier, N. Lederlin, P. Briere, J Dupriez, B. Sebban, C. Bosly, André[UCL] Biron, P. Nouvel, C. Herbrecht, R. Bordessoule, D. Coiffier, B. (2000) Journal of Clinical Oncology — Vol. 18, no. 6, p. 1309-1315 (2000)
4. • Journal article

   • 

   Efficacy and safety of rasburicase (recombinant urate oxidase) for the prevention and treatment of Hyperuricemia during induction chemotherapy of aggressive non-Hodgkin's lymphoma: Results of the GRAAL1

   Coiffier, B. Mounier, N. Bologna, S. Ferme, C Tilly, H. Sonet, Anne Christian, B. Casasnovas, O. Jourdan, E Belhadj, K Herbrecht, R. (2003) Journal of Clinical Oncology — Vol. 21, no. 23, p. 4402-4406 (2003)
5. • Journal article

   • 

   Rituximab plus CHOP (R-CHOP) overcomes bcl-2-associated resistance to chemotherapy in elderly patients with diffuse large B-cell lymphoma (DLBCL)

   Mounier, N. Briere, J Gisselbrecht, C. Emile, JF Lederlin, P. Sebban, C. Berger, F. Bosly, André[UCL] Morel, Priscilla[UCL] Tilly, H. Bouabdallah, R. Reyes, F. Gaulard, P. Coiffier, B. (2003) Blood — Vol. 101, no. 11, p. 4279-4284 (2003)
6. • Journal article

   • 

   Cryopreservation, semen use and the likelihood of fatherhood in male Hodgkin lymphoma survivors: An EORTC-GELA lymphoma group cohort study

   Van Der Kaaij, M.A.E. Van Echten-Arends, J. Heutte, N. Meijnders, P. Abeilard-Lemoisson, E. Spina, M. Moser, E.C. Allgeier, A. Meulemans, B. Lugtenburg, P.J. Aleman, B.M.P. Noordijk, E.M. Fermé, C. Thomas, J. Stamatoullas, A. Fruchart, C. Eghbali, H. Brice, P. Smit, W.G.J.M. Sebban, C. Doorduijn, J.K. Roesink, J.M. Gaillard, I. Coiffier, B. Lybeert, M.L.M. Casasnovas, O. André, Marc[UCL] Raemaekers, J.M.M. Henry-Amar, M. Kluin-Nelemans, J.C. (2014) Human Reproduction — Vol. 29, no.3, p. 525-533 (2014)
7. • Journal article

   • 

   Bone marrow transplantation prolongs survival after relapse in aggressive-lymphoma patients treated with the LNH-84 regimen.

   Bosly, André[UCL] Coiffier, B. Gisselbrecht, C. Tilly, H. Auzanneau, G. Andrien, F Herbrecht, R. Legros, M. Devaux, Y Jaubert, J. (1992) Journal of clinical oncology : official journal of the American Society of Clinical Oncology — Vol. 10, no. 10, p. 1615-23 (1992)
8. • Speech

   • 

   Autologous Hematopoietic Stem-cell Transplantation in Intermediate and High-grade Non-hodgkins-lymphoma - a Review

   Gisselbrecht, C. Bosly, André[UCL] Lepage, E. Reyes, F. Philip, T. Haioun, C. Tilly, H. Coiffier, B. (1993) INTERNATIONAL CONSENSUS CONF ON INTENSIVE CHEMOTHERAPY PLUS HEMATOPOIETIC STEM CELL TRANSPLANTATION IN MALIGNANCIES — LYON(France)
9. • Journal article

   • 

   Survival benefit of high-dose therapy in poor-risk aggressive non-Hodgkin's lymphoma: Final analysis of the prospective LNH87-2 protocol - A Groupe d'Etude des Lymphomes de l'Adulte Study

   Haioun, C. Lepage, E. Gisselbrecht, C. Salles, G. Coiffier, B. Brice, P. Bosly, André[UCL] Morel, Priscilla[UCL] Nouvel, C. Tilly, H. Lederlin, P. Sebban, C. Briere, J Gaulard, P. Reyes, F. (2000) Journal of Clinical Oncology — Vol. 18, no. 16, p. 3025-3030 (2000)
10. • Journal article

    • 

    Intensive chemotherapy plus hematopoietic stem cells transplantation for relapsing non-Hodgkin's lymphoma: the GELA experience.

    Bosly, André[UCL] Gisselbrecht, C. Coiffier, B. (1993) Nouvelle revue française d'hématologie — Vol. 35, no. 1, p. 21-3 (1993)
11. • Journal article

    • 

    Intensive conventional chemotherapy (ACVBP regimen) compared with standard CHOP for poor-prognosis aggressive non-Hodgkin lymphoma

    Tilly, H. Lepage, E. Coiffier, B. Blanc, M. Herbrecht, R. Bosly, André[UCL] Attal, M. Fillet, G. Guettier, C. Molina, TJ Gisselbrecht, C. Reyes, F. (2003) Blood — Vol. 102, no. 13, p. 4284-4289 (2003)
12. • Journal article

    • 

    Place de l'autogreffe dans le traitement des rechutes des lymphomes agressifs: expérience du GELA.

    Bosly, André[UCL] Coiffier, B. (1993) Pathologie-biologie — Vol. 41, no. 1, p. 97 (1993)
13. • Journal article

    • 

    [Role of Autologous Bone-marrow Transplantation in Relapsing Aggressive Lymphoma - the Gela Experience]

    Bosly, André[UCL] Coiffier, B. (1993) Pathologie et Biologie — Vol. 41, no. 1, p. 97-97 (1993)
14. • Journal article

    • 

    Outcome is not improved by the use of alternating chemotherapy in elderly patients with aggressive lymphoma.

    Bosly, André[UCL] Lepage, E. Coiffier, B. Fillet, G. Herbrecht, R. Divine, M. Dupriez, B. Nouvel, C. Deconninck, E Tilly, H. Bordessoule, D. Gaulard, P. Gisselbrecht, C. (2001) The hematology journal : the official journal of the European Haematology Association / EHA — Vol. 2, no. 4, p. 279-85 (2001)
15. • Journal article

    • 

    High-dose treatment with autologous stem cell transplantation versus sequential chemotherapy: the GELA experience.

    Bosly, André[UCL] Haioun, C. Gisselbrecht, C. Reyes, F. Coiffier, B. (2001) European journal of haematology. Supplementum — Vol. 64, p. 3-7 (2001)
16. • Journal article

    • 

    ABVD (8 cycles) versus BEACOPP (4 escalated cycles ≥4 baseline): Final results in stage III-IV low-risk Hodgkin lymphoma (IPS 0-2) of the LYSA H34 randomized trial

    Mounier, N. Brice, P. Bologna, S. Briere, J. Gaillard, I. Heczko, M. Gabarre, J. Casasnovas, O. Jaubert, J. Colin, P. Delmer, A. Devidas, A. Bachy, E. Nicolas-Virelizier, E. Aoudjhane, A. Humbrecht, C. André, M.[UCL] Carde, P. Divine, M. Fenaux, P. Coiffier, B. Reman, O. Aoudjhane, M. Blaise, A.M. Bordessoule, D. Bosly, André[UCL] Morschhauser, F. Caillot, D. Gonzalez, H. Lederlin, P. Bouabdallah, R. van Hoof, A. Boulat, O. Bauduer, F. Tournilhac, O. Decaudin, D. Sebban, C. Janvier, M. Kentos, A. Voillat, L. Fabbro, M. Eisenmann, J.C. Martin, C. Christian, B. Ferrant, Augustin[UCL] Salanoubat, C. Varet, B. Bouabdallah, K. de Prijck, B. Levaltier, X. Castaigne, S. Audhuy, B. Frenkiel, N. Rose, C. Fitoussi, O. Orfeuvre, H. Pignon, J.M. (2014) Annals of Oncology — Vol. 25, no.8, p. 1622-1628 (2014)
17. • Journal article

    • 

    Efficacy and toxicity of two schedules of bortezomib in patients with recurrent or refractory follicular lymphoma: A randomised phase II trial from the Groupe d'Etude des Lymphomes de l'Adulte (GELA)

    Ribrag, V. Tilly, H. Casasnovas, O. Bosly, André[UCL] Bouabdallah, R. Delarue, R. Boue, F. Bron, D. Feugier, P. Haioun, C. Offner, F. Coiffier, B. (2013) European Journal of Cancer — Vol. 49, no. 4, p. 904-910 (2013)
18. • Journal article

    • 

    Possible Toxicity With the Association of G-csf and Bleomycin

    Bastion, Y. Reyes, F. Bosly, André[UCL] Gisselbrecht, C. Yver, A. Gilles, E. Maral, J. Coiffier, B. (1994) The Lancet — Vol. 343, no. 8907, p. 1221-1222 (1994)
19. • Journal article

    • 

    ESTIC position paper: High-dose chemotherapy for breast cancer, investigation should continue

    Crown, J Coiffier, B. Cortes-Funes, H Guillaume, Th.[UCL] Kanz, L Kvalheim, G Marty, M Symann, Michel[UCL] (1999) Annals of Oncology — Vol. 10, no. 8, p. 903-905 (1999)
20. • Speech

    • 

    Final results of the efficacy and safety of rasburicase (recombinant urate oxydase) for the prevention and treatment of hyperuricemia in patients with aggressive lymphoma (GRAAL 1 study).

    Coiffier, B. Mounier, N. Bologna, S. Ferme, C Herbrecht, R. Tilly, H. Sonet, Anne Christian, B. Casasnovas, O. Jourdan, E Belhadj, K (2002) 44th Annual Meeting of the American-Society-of-Hematology — PHILADELPHIA(Pennsylvania)
21. • Speech

    • 

    A prospective multicentric phase II study of the C5R regimen in patients with primary cerebral lymphoma: Analysis on 70 patients.

    Blay, J. -Y. Perol, D. Sebban, C. Bosly, André[UCL] Casasnovas, O. Reman, O. Coiffier, B. Morel, Priscilla[UCL] (2001) —
22. • Journal article

    • 

    A multivariate analysis of the survival of patients with aggressive lymphoma - Variations in the predictive value of prognostic factors during the course of the disease

    Mounier, N. Morel, Priscilla[UCL] Haioun, C. Coiffier, B. Tilly, H. Chatelain, Christian Lederlin, P. Thyss, A Herbrecht, R. Gisselbrecht, C. Lepage, E. (1998) Cancer — Vol. 82, no. 10, p. 1952-1962 (1998)
23. • Journal article

    • 

    European School of Oncology - Management of Non-hodgkins-lymphomas - Conclusions of the European School of Oncology Meeting, 1986

    Coiffier, B. Bosly, André[UCL] Caligariscappio, F. Gisselbrecht, C. Patte, C. Schaadt, M. Symann, Michel[UCL] (1987) European Journal of Cancer and Clinical Oncology — Vol. 23, no. 11, p. 1691-1695 (1987)
24. • Speech

    • 

    Long term results of the GELA study, R-CHOP vs. CHOP in elderly patients with diffuse large B-cell lymphoma.

    Coiffier, B. Feugier, P Sebban, C. Bouabdallah, R. Delwail, V Tilly, H. Gisselbrecht, C. Bosly, André[UCL] Salles, G. Reyes, F. (2004) 46th Annual Meeting of the American-Society-of-Hematology — San Diego(Ca)
25. • Speech

    • 

    High-dose therapy followed by stem cell transplantation in partial response after first-line induction therapy for aggressive non-Hodgkin's lymphoma

    Haioun, C. Lepage, E. Gisselbrecht, C. Coiffier, B. Doyen, Chantal Morel, Priscilla[UCL] Attal, M. Tilly, H. Deconinck, E Gaulard, P. Reyes, F. (1998) International Consensus Conference on High-Dose Therapy with Hematopoietic Stem Cell Transplantation in Diffuse Large-Cell Lymphoma — LYON(France)

Pages